InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,190.80
(
1.23%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.19
(
-1.27%
)
Bitcoin
61,992.19
(
2.86%
)
Post# of 182958
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BlazingStocks

Send PM Follow Ignore
Followers 167
Posts 36091
Boards Moderated 7
Alias Born 10/20/2019

BlazingStocks

Member Level

Re: glenn1919 post# 182791

Tuesday, 01/09/2024 12:50:34 PM

Tuesday, January 09, 2024 12:50:34 PM

Post# of 182958
$NBIO - Management highlights the research as corroborating its own sense that Pritumumab (PTB) is a potential breakthrough therapy in the $1.8 billion underserved brain cancer market.
https://finance.yahoo.com/news/nascent-biotech-receives-analyst-opinion-130000256.html

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up